Search arXiv⌕ Search
Home/Archive/arXiv

arXiv · q-bio/0409016

Outcome signature genes in breast cancer: is there a unique set?

Liat Ein-Dor·Itai Kela·Gad Getz·David Givol·Eytan Domany
View original source ↗Read source document ↗Export metadata ↓

Abstract

Motivation: Predicting the metastatic potential of primary malignant tissues has direct bearing on choice of therapy. Several microarray studies yielded gene sets whose expression profiles successfully predicted survival (Ramaswamy et al 2003; Sorlie et al 2001; van't Veer et al 2003). Nevertheless, the overlap between these gene sets is almost zero. Such small overlaps were observed also in other complex diseases (Lossos et al 2003; Miklos and Maleszka 2004), and the variables that could account for the differences had evoked a wide interest. One of the main open questions in this context is whether the disparity can be attributed only to trivial reasons such as different technologies, different patients and different types of analysis. Results: To answer this question we concentrated on one single breast cancer dataset, and analyzed it by one single method, the one which was used by van't Veer et al to produce a set of outcome predictive genes. We showed that in fact the resulting set of genes is not unique; it is strongly influenced by the subset of patients used for gene selection. Many equally predictive lists could have been produced from the same analysis. Three main properties of the data explain this sensitivity: (a) many genes are correlated with survival; (b) the differences between these correlations are small; (c) the correlations fluctuate strongly when measured over different subsets of patients. A possible biological explanation for these properties is discussed.

Explore related subjects

q-bio.QMq-bio.GN

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Liat Ein-Dor, Itai Kela, Gad Getz, David Givol, Eytan Domany. 2004-09-14. Outcome signature genes in breast cancer: is there a unique set?. https://arxiv.org/abs/q-bio/0409016

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

scTREAT: Latent Diffusion for Single-Cell Drug-Response Prediction

Generating drug-induced transcriptional responses requires a model to account for cellular background together with molecular identity and dose. We present scTREAT, the first diffusion framework to factorize state and drug guidance for single-cell drug-response prediction. A shared latent expression space connects baseline and response, while Guided Decomposable Attention (GD-Attn) injects a baseline representation and a dose-conditioned molecular embedding. Independent channel dropout exposes four conditioning states during training; inference combines three conditional predictions with separately specified state and drug coefficients, and dose modulates drug-guidance strength. On condition-level pseudobulk profiles derived from the Tahoe-100M single-cell atlas, scTREAT achieves the best value on 10 of 12 metrics for unseen cell line-drug combinations (UC) and 11 of 12 for unseen drugs (UD). Ablations examine condition injection, molecular representation, and guidance design. On UD, the relative gains over the second-best model reach 36.11% and 34.21% for DEG logFC-Spearman and logFC-Pearson. These results demonstrate the effectiveness of combining shared latent expression modeling with explicit state and drug conditioning for response prediction.

q-bio.QM↗
arXiv2026

scDNM-VAE enables directly inspectable deep clustering of single-cell RNA-seq data through signed dendritic gating

Deep clustering models for single-cell RNA sequencing often assign cells through latent or centroid-based mechanisms that are difficult to inspect. We introduce scDNM-VAE (single-cell Dendritic Neuron Model Variational Autoencoder), a deep clustering framework that combines a variational autoencoder with a dendritic neuron-inspired head. Cluster assignments are governed by learnable signed synaptic weights and thresholds: the weight sign determines the direction of a gate's response to a latent coordinate, its magnitude controls steepness, and the weight-threshold pair determines the transition location. The trained clustering function can therefore be inspected directly without fitting a post-hoc explanation model. We benchmark scDNM-VAE on four datasets spanning immune, cortical, cardiac, and hematopoietic cells against scVI followed by KMeans and an MLP-DEC ablation. scDNM-VAE performs better than scVI on PBMC3k, comparably on the Human Heart Cell Atlas and Paul15, and worse on Zeisel, while producing biologically coherent marker-gene signatures. Ablating each cluster's three highest-magnitude synaptic dimensions causes numerically greater reassignment than random-dimension ablation across all datasets, but the margins are modest and negligible on Zeisel. These results show that signed dendritic gating supports competitive clustering with a parameter-inspectable decision function, while indicating that decision-relevant information is distributed across the latent space.

q-bio.QM↗
arXiv2026

Leveraging deep generative modelling at the agent level in discrete-event simulations

Emulators are often invoked to facilitate parameter inference in computationally intensive agent-based simulations (ABSs). Most approaches, however, require a large sample of pre-existing outputs on which such emulators can be trained. For computationally intensive simulations, this sample can be prohibitively expensive to generate. We propose a new approach to leverage emulators at the agent level in event-based ABSs to reduce the computational requirements of the simulation itself. We demonstrate this in a computationally intensive ``multi-disease'' ABS, Thanzi La Onse, which self-consistently simulates a wide range of medical conditions in a population. By applying conditional tabular generative adversarial networks to replace the modelling of one of the simulated causes of ill health, road traffic injuries (RTIs), we are able to improve its simulation run-time by 86.6% (95% bootstrap confidence interval [85.2, 88.1]), while recovering the evolution of cause-specific mean disability adjusted life years with a 13% error, despite the low assumed incidence of fatal RTIs (~2%). Crucially, we do so while retaining the full ABS framework, and correctly recovering multi-disease dynamics. This represents a crucial step towards enabling full-model emulators for very computationally intensive simulations, and making large ABS amenable to rigorous parameter inference and a full understanding of parameter sensitivity.

q-bio.QM↗